Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Local (Brazil) study, multicenter, opened, comparative, randomized, with parallel groups, phase IV, in post menopausal woman with Colles' fracture of the risedronate sodium [risedronic acid] usage in the consolidation and in the callus of the Colles' fracture.

Trial Profile

Local (Brazil) study, multicenter, opened, comparative, randomized, with parallel groups, phase IV, in post menopausal woman with Colles' fracture of the risedronate sodium [risedronic acid] usage in the consolidation and in the callus of the Colles' fracture.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Oct 2011

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Risedronic acid (Primary) ; Calcium; Colecalciferol
  • Indications Postmenopausal osteoporosis
  • Focus Therapeutic Use
  • Acronyms SOLID
  • Sponsors Sanofi

Most Recent Events

  • 03 Oct 2011 Actual trial end date (Sep 2007) added as reported by ClinicalTrials.gov.
  • 03 Oct 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
  • 06 Apr 2011 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top